485 related articles for article (PubMed ID: 8244419)
1. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A
Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419
[TBL] [Abstract][Full Text] [Related]
2. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
4. A new immunization protocol for the production of monoclonal antibodies specific for VL subgroups of human immunoglobulins.
Goto T; Abe M; Kosaka M
Tokushima J Exp Med; 1990 Dec; 37(3-4):89-96. PubMed ID: 2128783
[TBL] [Abstract][Full Text] [Related]
5. Serologically defined V region subgroups of human lambda light chains.
Solomon A; Weiss DT
J Immunol; 1987 Aug; 139(3):824-30. PubMed ID: 3110284
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
[TBL] [Abstract][Full Text] [Related]
7. Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies.
Davern S; Tang LX; Williams TK; Macy SD; Wall JS; Weiss DT; Solomon A
Am J Clin Pathol; 2008 Nov; 130(5):702-11. PubMed ID: 18854262
[TBL] [Abstract][Full Text] [Related]
8. Variable-region subgroup distribution among lambda-type immunoglobulins in normal human serum.
Abe M; Ozaki S; Wolfenbarger D; deBram-Hart M; Weiss DT; Solomon A
J Clin Lab Anal; 1994; 8(1):4-9. PubMed ID: 8164110
[TBL] [Abstract][Full Text] [Related]
9. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations in the variable region of the lambda 2 chain of M315 suppression of antibodies to the idiotype of M315.
Sakato N; Azuma T; Fujio H
Biken J; 1985 Dec; 28(3-4):51-8. PubMed ID: 2423068
[TBL] [Abstract][Full Text] [Related]
11. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
Frangione B; Moloshok T; Solomon A
J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
[TBL] [Abstract][Full Text] [Related]
12. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
Solomon A; Frangione B; Franklin EC
J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
[TBL] [Abstract][Full Text] [Related]
13. [Study of the antigenic structure of human immunoglobulin lambda-chain using monoclonal antibodies].
Arsen'eva EL; Bogacheva GT; Solomon A; Weiss D; Ibragimov AR; Rokhlin OV
Mol Biol (Mosk); 1990; 24(1):117-26. PubMed ID: 1693412
[TBL] [Abstract][Full Text] [Related]
14. Serologic and chemical differentiation of human lambda III light chain variable regions.
Eulitz M; Murphy C; Weiss DT; Solomon A
J Immunol; 1991 May; 146(9):3091-6. PubMed ID: 1901892
[TBL] [Abstract][Full Text] [Related]
15. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
Sanchez de cos Escuin J; Moreno Norueira J; Carneado de la Fuente J
Rev Clin Esp; 1978 Sep; 150(6):345-9. PubMed ID: 103147
[No Abstract] [Full Text] [Related]
16. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
[TBL] [Abstract][Full Text] [Related]
17. Chemical and serologic characterization of human lambda VIII light chains.
Solomon A; Weiss DT; Murphy C; Fu SM; Robbins DL
J Immunol; 1994 Aug; 153(4):1658-64. PubMed ID: 8046238
[TBL] [Abstract][Full Text] [Related]
18. Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains.
Lowe J; Hardie D; Jefferis R; Ling NR; Drysdale P; Richardson P; Raykundalia C; Catty D; Appleby P; Drew R; Maclennan IC
Immunology; 1981 Apr; 42(4):649-59. PubMed ID: 6786981
[TBL] [Abstract][Full Text] [Related]
19. T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region.
Bogen B; Jørgensen T; Hannestad K
Eur J Immunol; 1985 Mar; 15(3):278-81. PubMed ID: 2579823
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies specific for variable and constant domains of murine lambda chains.
Bogen B
Scand J Immunol; 1989 Mar; 29(3):273-9. PubMed ID: 2497510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
